These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 18066075

  • 1. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
    Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD.
    Nat Med; 2008 Jan; 14(1):45-54. PubMed ID: 18066075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. From lung injury to fibrosis.
    Ley K, Zarbock A.
    Nat Med; 2008 Jan; 14(1):20-1. PubMed ID: 18180715
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
    Tang N, Zhao Y, Feng R, Liu Y, Wang S, Wei W, Ding Q, An MS, Wen J, Li L.
    J Cell Mol Med; 2014 Jan; 18(1):156-69. PubMed ID: 24251962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE, Berdyshev E, Bain G, Castelino FV, Shea BS, Probst CK, Fontaine BA, Bronova I, Goulet L, Lagares D, Ahluwalia N, Knipe RS, Natarajan V, Tager AM.
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [Abstract] [Full Text] [Related]

  • 9. Regulation of silicosis formation by lysophosphatidic acid and its receptors.
    Cong C, Mao L, Zhang Y, Zhao Z, Xu X, Zhao J.
    Exp Lung Res; 2014 Sep; 40(7):317-26. PubMed ID: 24926730
    [Abstract] [Full Text] [Related]

  • 10. A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
    Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS, Santini AM, Hutchinson JH, Seiders TJ, Parr TA, Prasit P, Evans JF, Lorrain DS.
    Br J Pharmacol; 2010 Aug; 160(7):1699-713. PubMed ID: 20649573
    [Abstract] [Full Text] [Related]

  • 11. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
    Sakai N, Chun J, Duffield JS, Wada T, Luster AD, Tager AM.
    FASEB J; 2013 May; 27(5):1830-46. PubMed ID: 23322166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.
    Qian Y, Hamilton M, Sidduri A, Gabriel S, Ren Y, Peng R, Kondru R, Narayanan A, Truitt T, Hamid R, Chen Y, Zhang L, Fretland AJ, Sanchez RA, Chang KC, Lucas M, Schoenfeld RC, Laine D, Fuentes ME, Stevenson CS, Budd DC.
    J Med Chem; 2012 Sep 13; 55(17):7920-39. PubMed ID: 22894757
    [Abstract] [Full Text] [Related]

  • 18. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
    van den Brule S, Wallemme L, Uwambayinema F, Huaux F, Lison D.
    J Pharmacol Exp Ther; 2010 Nov 13; 335(2):472-9. PubMed ID: 20719937
    [Abstract] [Full Text] [Related]

  • 19. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.
    Fabre A, Marchal-Sommé J, Marchand-Adam S, Quesnel C, Borie R, Dehoux M, Ruffié C, Callebert J, Launay JM, Hénin D, Soler P, Crestani B.
    Eur Respir J; 2008 Aug 13; 32(2):426-36. PubMed ID: 18321937
    [Abstract] [Full Text] [Related]

  • 20. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
    Zhao J, Wei J, Weathington N, Jacko AM, Huang H, Tsung A, Zhao Y.
    Transl Res; 2015 Jul 13; 166(1):80-8. PubMed ID: 25701366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.